Health Condition 1: null- bronchial asthma
Conditions
Interventions
Intervention1: vitamin D and inhalers containing formoterol and budesonide: oral capsules of 400 IU of vitamin D daily for 8 weeks. MDI formoterol(6microgram) and budesonide(200microgram) 2puffs bd fo
Sponsors
Vallabhbhai Patel Chest Institute
Eligibility
Inclusion criteria
Inclusion criteria: clinical findings and spirometry interpretations consistent with diagnosis of bronchial asthma.
Exclusion criteria
Exclusion criteria: hospitalization during past 4 weeks patients with other respiratory and syatemic diseases other than allergic rhinitis and GERD pregnant,lactating and postmenopausal females history of intake of vitamin d and calcium in past 1 month diagnosis of osteoporosis and other diseses involving viatmin d in calcium metabolism history of renal disorders,thyroidectomy and liver disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| control of asthma by the asthma control questionnaire at 2 weeks and 8 weeks. effect on inflammatory markers(ECP, IL-10,IL-13,serum IGE and AEC at 2 weeks and 8 weeks. effect on FEV1,FVC,FEV1/FVC ratio and FEF25-75 at 2 weeks and 8 weeksTimepoint: outcomes will be assessed at the end of 8 weeks study period | — |
Secondary
| Measure | Time frame |
|---|---|
| effect on hospitalistion requencyTimepoint: at the end of 10 weeks | — |
Countries
India
Contacts
Public ContactDr Balakrishnan Menon
Vallabhai Patel Chest Institute
Outcome results
None listed